For many applications, the Australian Pesticides and Veterinary Medicines Authority (APVMA) is required to publish a summary of the application once the applicant has been notified that the application has been accepted for assessment. The summary will be removed once the application is finalised.
The types of applications requiring an application summary include those for new active constituents, products and labels and applications involving variation to products and labels, where the variation involves a change in the use, supply or disposal of the product.
The summaries include details of the applications as specified in Divisions 2.1 and 2.2 of the regulations.
Please remember to follow the guidance for preparing information lists when preparing your application to avoid sensitive information being published.
For more information, please see the questions and answers.
Use the filter and links below to find and view application summaries.
Date
Application Date
Application No
Application Number
144578
Product/Active constituent Name
Application Product Name
PHOSIC 600 SYSTEMIC FUNGICIDE
Application Date
Application Number
144578
Application Product Name
PHOSIC 600 SYSTEMIC FUNGICIDE
Application details
Product name:
PHOSIC 600 SYSTEMIC FUNGICIDE
Product number:
62941
Applicant Name:
S.J.B. AG-NUTRI PTY. LTD.
Application purpose and description of use:
Variation of the label only:
Active constituents:
Active constituent name
61284 - PHOSPHONIC ACID
Date
Application Date
Application No
Application Number
144598
Product/Active constituent Name
Application Product Name
[Wagg & Purr] Carprofen 75 mg Chewable Tablets for Dogs
Application Date
Application Number
144598
Application Product Name
[Wagg & Purr] Carprofen 75 mg Chewable Tablets for Dogs
Application details
Product name:
[Wagg & Purr] Carprofen 75 mg Chewable Tablets for Dogs
Product number:
95078
Applicant Name:
AVET HEALTH LIMITED
Application purpose and description of use:
Registration of a 75 mg carpforen chewable tablet product for used as a non-steroidal anti-inflammatory drug (NSAID) in dogs.
Reference details:
52469 - RIMADYL 75MG CHEWABLE TABLETS FOR DOGS
Active constituents:
Active constituent name
95072 - Carprofen
Description of data provided:
Data no
273846
Title
Product specifications 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273847
Title
Product specifications 2
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Date
Application Date
Application No
Application Number
144599
Product/Active constituent Name
Application Product Name
[Wagg & Purr] Carprofen 25 mg Chewable Tablets for Dogs
Application Date
Application Number
144599
Application Product Name
[Wagg & Purr] Carprofen 25 mg Chewable Tablets for Dogs
Application details
Product name:
[Wagg & Purr] Carprofen 25 mg Chewable Tablets for Dogs
Product number:
95079
Applicant Name:
AVET HEALTH LIMITED
Application purpose and description of use:
Registration of a 25 mg carpforen chewable tablet product for used as a non-steroidal anti-inflammatory drug (NSAID) in dogs.
Reference details:
52468 - RIMADYL 25MG CHEWABLE TABLETS FOR DOGS
Active constituents:
Active constituent name
95072 - Carprofen
Description of data provided:
Data no
273848
Title
Product specifications 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273849
Title
Product specifications 2
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Date
Application Date
Application No
Application Number
144590
Product/Active constituent Name
Application Product Name
Carprofen
Application Date
Application Number
144590
Application Product Name
Carprofen
Application details
Product name:
Carprofen
Active name:
Carprofen
Applicant Name:
AVET HEALTH LIMITED
Application purpose and description of use:
New source of pharmacopoeia active constituent.
Description of data provided:
Data no
275658
Title
Active certificates of analysis
Study date
2023
Auth party contact address
Level 4 24-28 Collins Street MELBOURNE Australia
Date
Application Date
Application No
Application Number
144895
Product/Active constituent Name
Application Product Name
Cyproconazole
Application Date
Application Number
144895
Application Product Name
Cyproconazole
Application details
Product name:
Cyproconazole
Active name:
Cyproconazole
Applicant Name:
SYNGENTA AUSTRALIA PTY LTD
Application purpose and description of use:
Approval of Cyproconazole for use in agricultural products.
Description of data provided:
Data no
275817
Title
Determination of Cyproconazole tech. by HPLC - Analytical Method SA-166/1
Study date
05 October 2020
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275818
Title
Cyproconazole tech - Determination of By-Products and Supplementary Tests by UHPLC and Capillary Gas Chromatography
Study date
05 October 2020
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275816
Title
Cyproconazole- Analysis of Five Representative Batches
Study date
07 March 2024
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275814
Title
CYPROCONAZOLE - MANUFACTURING PROCESS
Study date
10 June 2024
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275815
Title
Declaration of Composition
Study date
25 July 2024
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275819
Title
Cyproconazole ??? Validation of Analytical Method SA-166/1
Study date
28 Feb 2018
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275820
Title
Cyproconazole ??? Validation of Analytical Method SB-166/1
Study date
27 September 2018
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275811
Title
Part 2 - Chemistry and Manufacture
Study date
30 July 2024
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275812
Title
Statement on UV wavelength screening of Cyproconazole by Diodearray
Study date
20 January 2021
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Data no
275813
Title
Cyproconazole - Identification of Cyproconazole and its Impurities in Five Representative Batches
Study date
14 June 2024
Auth party contact address
LEVEL 1, 2 LYONPARK ROAD MACQUARIE PARK Australia
Date
Application Date
Application No
Application Number
144589
Product/Active constituent Name
Application Product Name
[Wagg & Purr] Carprofen 100 mg Chewable Tablets for Dogs
Application Date
Application Number
144589
Application Product Name
[Wagg & Purr] Carprofen 100 mg Chewable Tablets for Dogs
Application details
Product name:
[Wagg & Purr] Carprofen 100 mg Chewable Tablets for Dogs
Product number:
95071
Applicant Name:
AVET HEALTH LIMITED
Application purpose and description of use:
Registration of a 100 mg carprofen chewable tablet product for use as a non-steroidal anti-inflammatory drug (NSAID) in dogs.
Reference details:
52470 - RIMADYL 100MG CHEWABLE TABLETS FOR DOGS
Active constituents:
Active constituent name
95072 - Carprofen
Description of data provided:
Data no
273821
Title
Analytical method report 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273822
Title
Analytical method report 2
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273823
Title
Analytical method report 3
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273824
Title
Analytical method report 4
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273825
Title
Analytical validation report 1
Study date
2019
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273826
Title
Analytical validation protocol and report 2
Study date
2019
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273827
Title
Analytical validation protocol and report 3
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273818
Title
Certificate of analysis 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273819
Title
Certificate of analysis 2
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273820
Title
Certificate of analysis 3
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273815
Title
Product specifications 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273816
Title
Product specifications 2
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273817
Title
Product specifications justification
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
286238
Title
Product specifications justification data
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
286239
Title
Monograph
Study date
2025
Auth party contact address
-
Data no
273797
Title
Excipients certificates of analysis
Study date
2022
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273798
Title
Excipient 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273799
Title
Excipient 2
Study date
2022
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273800
Title
Manufacturing flowchart
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273801
Title
Manufacturing description
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273802
Title
Process validation protocol
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273803
Title
Process validation report
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273804
Title
Process validation packaging report 1
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273805
Title
Process validation packaging report 2
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273806
Title
Process validation packaging report 3
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273807
Title
Process validation packaging report 4
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273808
Title
Process validation packaging report 5
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273809
Title
Process validation packaging report 6
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273810
Title
In process controls
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273811
Title
Process validation protocol
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273812
Title
Process validation report
Study date
2022
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273813
Title
Packaging 1
Study date
2018
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273814
Title
Packaging 2
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
286240
Title
Explanation letter
Study date
2025
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
293437
Title
Explanation letter
Study date
2025
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273843
Title
Efficacy study 4
Study date
2024
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
286235
Title
Excipient 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
286236
Title
Excipient 2
Study date
2025
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273795
Title
Part 2 dossier
Study date
2024
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273828
Title
Stability report 1
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273829
Title
Stability report 2
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273830
Title
Stability report 3
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273831
Title
Stability report 4
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273832
Title
Stability report 5
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273833
Title
Stability report 6
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273834
Title
Stability report 7
Study date
2021
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273840
Title
Efficacy study 1
Study date
2018
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273841
Title
Efficacy study 2
Study date
2017
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273842
Title
Efficacy study 3
Study date
2018
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
286237
Title
ICH M13B Guideline
Study date
2025
Auth party contact address
-
Data no
273835
Title
Part 8 Efficacy and Safety dossier
Study date
2024
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273836
Title
Pharmacology
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273837
Title
Handbook of Pharmaceutical Excipients
Study date
2017
Auth party contact address
-
Data no
273838
Title
Excipient 1
Study date
2020
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273839
Title
Excipient 2
Study date
2022
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273789
Title
GMP certificate 1
Study date
2022
Auth party contact address
-
Data no
273790
Title
GMP report redacted 1
Study date
2024
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273791
Title
GMP report 1
Study date
2024
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273792
Title
GMP certificate 2
Study date
2024
Auth party contact address
-
Data no
273793
Title
GMP report redacted 2
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Data no
273794
Title
GMP report 2
Study date
2023
Auth party contact address
Rialto, L2 Podium East 525 Collins Street MELBOURNE Australia
Date
Application Date
Application No
Application Number
144595
Product/Active constituent Name
Application Product Name
Flg22-Bt Peptide
Application Date
Application Number
144595
Application Product Name
Flg22-Bt Peptide
Application details
Product name:
Flg22-Bt Peptide
Product number:
95075
Applicant Name:
ELEMENTAL ENZYMES AUSTRALIA PTY LTD
Application purpose and description of use:
Item 2 application for approval of new active constituent Flg22-Bt Peptide and registration of formulated product Vismax Specialty 95076/144596.
Description of data provided:
Data no
274272
Title
Five Batch Analysis of Flg22-Bt Peptide Technical
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274273
Title
Five Batch Analysis of Flg22-Bt Peptide Technical
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274274
Title
Addendum_Flg22-BtPeptideTechnical_5BatchAnalysis
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274270
Title
Flg22Bt-PeptideTechnical_MFGProcess
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274271
Title
Flg22Bt-PeptideTechnical_MFGProcess - SDS raw materials
Study date
2024
Auth party contact address
-
Data no
274275
Title
COA's for Active
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274276
Title
Declaration of Composition_Active
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274277
Title
VISMAX Specialty Crops - chemistry report for active
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274278
Title
Flg22-BtPeptideTechnical_Elemental Analysis
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274279
Title
Email to APVMA_LOQ_LOD
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274280
Title
APVMA response_LOD_LOQ
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274262
Title
TGAI Appearance
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274263
Title
TGAI Melting point
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274264
Title
TGAI pH
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274265
Title
TGAI Bulk Density
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274266
Title
TGAI Partition Coefficient
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274267
Title
TGAI Water Solubility
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274268
Title
TGAI Organic Solvent Solubility
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274269
Title
TGAI UV Visible Absorption
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274261
Title
PART 2 CHEMISTRY & MANUFACTURE
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274285
Title
Flg22-BtPeptideTechnical_AcuteDermalIrritationRabbit
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274282
Title
Flg22-BtPeptideTechnical_AcuteDermalToxicityRat
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274283
Title
Flg22-BtPeptideTechnical_AcuteInhalationToxicityRat
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274281
Title
Flg22-BtPeptideTechnical_AcuteOralToxicityRat
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274284
Title
Flg22-BtPeptideTechnical_AcuteDermalIrritationRabbit
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274286
Title
Flg22-BtPeptideTechnical_LLNASkinSensitization
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Date
Application Date
Application No
Application Number
144596
Product/Active constituent Name
Application Product Name
Vismax Specialty
Application Date
Application Number
144596
Application Product Name
Vismax Specialty
Application details
Product name:
Vismax Specialty
Product number:
95076
Applicant Name:
ELEMENTAL ENZYMES AUSTRALIA PTY LTD
Application purpose and description of use:
Item 2 application for approval of new active constituent Flg22-Bt Peptide and registration of formulated product Vismax Specialty containing not less than 0.065g/L Flg22-Bt Peptide for use on almonds.
Description of data provided:
Data no
274177
Title
EUP Method Validation
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274172
Title
EUP manufacturing process
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274173
Title
EUP Appearance
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274174
Title
EUP pH
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274175
Title
EUP Viscosity
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274176
Title
EUP SpecificGravity
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274178
Title
VISMAX Specialty Crops - Chemistry report product
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274179
Title
Specialty Item 25 Cover Letter
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274180
Title
Dissociation Constant Waiver
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274170
Title
PAA Written Advice
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274171
Title
SDS for non-active ingredients
Study date
2024
Auth party contact address
-
Data no
274182
Title
APVMA written advice
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274183
Title
Persistent Foam
Study date
2022
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274185
Title
Flg22-Bt0.012%FormulationA_AcceleratedAging
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274184
Title
Flg22-Bt0.012%FormulationA_Storage Stability
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274181
Title
Flg22-BtPeptideTechnical_Storage Stability
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274246
Title
Vismax Efficacy Report_Shothole_Almonds_AGX23144
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274247
Title
Vismax Efficacy Report_Shothole_Almonds_AGX22184
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274248
Title
Vismax Efficacy Report_Shothole_Almonds_AGX22182
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274249
Title
Vismax Efficacy Report_Shothole_Almonds_AGX22183
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274250
Title
Vismax Efficacy Report_Shothole_Almonds_AGX22181
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274251
Title
Vismax Efficacy Report_Shothole_Almonds_AGX22180
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274252
Title
Vismax Efficacy Report_Shothole_Almonds_AGX23146
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274253
Title
Vismax Efficacy Report_Shothole_Almonds_AGX23145
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274255
Title
Vismax Efficacy Report_Shothole_Almonds_California_535
Study date
2021
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274256
Title
Vismax Efficacy Report_Shothole_Almonds_California_536
Study date
2021
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274257
Title
Vismax Efficacy Report_Shothole_Almonds_California_531
Study date
2021
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274258
Title
Email from Director Efficacy and Safety
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274245
Title
Part 8 Efficacy
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274254
Title
COA_G296A-252025_AU
Study date
2022
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274224
Title
Focus Surface Water Modelling
Study date
2021
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274225
Title
Focus Surface Water Modelling - soil application
Study date
2021
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274214
Title
Flg22-BtPeptideTechnical_Hydrolysis
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274218
Title
Flg22-BtPeptideTechnical_RainbowTrout96-hrAcute
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274219
Title
Flg22-BtPeptideTechnical_AcuteImmobilizationDaphnia
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274220
Title
Flg22-BtPeptideTechnical_DaphniaMethodValidation
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274228
Title
Flg22-BtPeptideTechnical_AlgaeToxicity
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
282767
Title
Effects of Flg22-Bt Peptide on Non-target Soil Dwelling Organisms
Study date
2025
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
282768
Title
REPRODUCTION TOXICITY TEST OF FLG22-Bt PEPTIDE TECHNICAL TO EARTHWORM, Eisenia fetida
Study date
Dec 2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
282765
Title
Flg22-Bt Peptide Technical: Effects on Reproduction of Collembola (Folsomia candida) in Artificial Soil
Study date
October 2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274221
Title
Flg22-BtPeptideTechnical_AcuteOralToxicityHoneybee
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274222
Title
Flg22-BtPeptideTechnical_AcuteContactToxicityHoneybee
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
282766
Title
Flg22-Bt Peptide Technical: Effects on Reproduction of the Predatory Mite Hypoaspis aculeifer in Artificial Soil
Study date
October 2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274233
Title
Almond vigour
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274234
Title
Tomato vigour
Study date
2022
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274235
Title
Eggplant vigour
Study date
2021
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274236
Title
Turfgrass vigour
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274237
Title
Canola vigour
Study date
2021
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274238
Title
Potato vigour
Study date
2022
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274223
Title
Flg22-Bt_0.012% FormulationA_SeedlingEmergence
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274212
Title
Part 7 - Environment
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274229
Title
No direct antimicrobial effect
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274230
Title
Flg22-BtPeptideTechnical_InVitroDigestion
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274231
Title
TGAI Water Solubility
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274232
Title
TGAI Organic Solvent Solubility
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274226
Title
Flg22-Bt Technical_Vegetative Vigor Waiver_
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274239
Title
90973-130629 Environmental technical report
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274240
Title
90973-130629 Attachment 1 - study summaries - fate
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274241
Title
90973-130629 Attachment 2 - study summaries - effects
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274242
Title
Specialty Item 25 Cover Letter
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274243
Title
PAA written advice_138578
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274244
Title
Meeting Minutes_141322
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274227
Title
Flg22-BtPeptideTechnical_SoilOrganismsWaiver
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274217
Title
Flg22-BtPeptideTechnical_AvianAcuteOralToxicity
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274259
Title
Executive Summary
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274207
Title
Part 6 OHS - VismaxTM Specialty Crops Item 2
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274208
Title
PAA Written Advice
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274209
Title
Transdermal Delivery of Proteins
Study date
2011
Auth party contact address
-
Data no
274210
Title
Vismax Specialty Crops_SDS _AUS_June 2024
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274211
Title
Vismax Specialty Crops - HHRA FTR
Study date
2022
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274203
Title
Residues Scientific Arugment
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274204
Title
PAA Written Advice
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274205
Title
Flg22-BtPeptideTechnical_InVitroDigestion
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274206
Title
Vismax Specialty Crops_130629_Residues
Study date
2022
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274194
Title
Flg22-Bt0.012%FormulationA_AcuteEyeIrritationRabbit
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274202
Title
Flg22-Bt0.012%FormulationA_AcuteEyeIrritationRabbit
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274193
Title
Flg22-Bt0.012%FormulationA_AcuteInhalationRat
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274192
Title
Flg22-Bt0.012%FormulationA_AcuteOralRat
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274201
Title
Flg22-Bt0.012%FormulationA_AcuteOralRat
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274188
Title
Flg22-BtPeptideTechnical_BacterialReverseMutation
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274189
Title
Flg22-BtPeptideTechnical_InVitroMammalianForwardMutation
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274190
Title
Flg22-BtPeptideTechnical_InVitroDigestion
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274191
Title
Flg22-BtPeptideTechnical_Allergenicity
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274186
Title
PART 3 ??? TOXICOLOGY
Study date
2024
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274187
Title
PAA Written Advice
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274195
Title
Flg22-Bt0.012%FormulationA_AcuteDermalIrritationRabbit
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274196
Title
Flg22-Bt0.012%FormulationA_LLNASkinSensitization
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274197
Title
SDS for non-active ingredients
Study date
2024
Auth party contact address
-
Data no
274198
Title
Vismax Specialty Crops - HHRA FTR
Study date
2022
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274199
Title
PAA written advice_138578
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274200
Title
Meeting Minutes_141322
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274213
Title
PAA Written Advice
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274215
Title
Flg22-BtPeptideTechnical_ReadyBiodegradability
Study date
2020
Auth party contact address
6 Palm Street FAIRFIELD Australia
Data no
274216
Title
Flg22-BtPeptideTechnical_ReadyBiodegradability
Study date
2023
Auth party contact address
6 Palm Street FAIRFIELD Australia
Date
Application Date
Application No
Application Number
144827
Product/Active constituent Name
Application Product Name
Conquest Atomic 200 Selective Herbicide
Application Date
Application Number
144827
Application Product Name
Conquest Atomic 200 Selective Herbicide
Application details
Product name:
Conquest Atomic 200 Selective Herbicide
Applicant Name:
CONQUEST CROP PROTECTION PTY LTD
Application purpose and description of use:
To register a 200 g/L formulation of quizalofop-p-ethyl for the control of certain grass weeds in broadleaf crops as per Directions for Use.
Date
Application Date
Application No
Application Number
144474
Product/Active constituent Name
Application Product Name
ADVANTIX FOR DOGS OVER 25KG
Application Date
Application Number
144474
Application Product Name
ADVANTIX FOR DOGS OVER 25KG
Application details
Product name:
ADVANTIX FOR DOGS OVER 25KG
Product number:
58262
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Elanco is submitting this application to request a reduction in the storage conditions for Advantix for Dogs over 25kg (APVMA no. 58262).
Active constituents:
Active constituent name
49016 - IMIDACLOPRID
Active constituent name
54244 - PERMETHRIN
Description of data provided:
Data no
273293
Title
Advantix Stability report
Study date
24-03-2020
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Date
Application Date
Application No
Application Number
144475
Product/Active constituent Name
Application Product Name
ADVANTIX FOR DOGS 10-25KG
Application Date
Application Number
144475
Application Product Name
ADVANTIX FOR DOGS 10-25KG
Application details
Product name:
ADVANTIX FOR DOGS 10-25KG
Product number:
58260
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Elanco is submitting this application to request a reduction in the storage conditions for Advantix for Dogs 10-25 kg (APVMA no.58260).
Active constituents:
Active constituent name
49016 - IMIDACLOPRID
Active constituent name
54244 - PERMETHRIN
Date
Application Date
Application No
Application Number
144476
Product/Active constituent Name
Application Product Name
ADVANTIX FOR DOGS 4-10KG
Application Date
Application Number
144476
Application Product Name
ADVANTIX FOR DOGS 4-10KG
Application details
Product name:
ADVANTIX FOR DOGS 4-10KG
Product number:
58261
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Elanco is submitting this application to request a reduction in the storage condition for Advantix for Dogs 4-10 kg (APVMA no. 58261).
Active constituents:
Active constituent name
49016 - IMIDACLOPRID
Active constituent name
54244 - PERMETHRIN
Date
Application Date
Application No
Application Number
144477
Product/Active constituent Name
Application Product Name
ADVANTIX FOR PUPPIES AND SMALL DOGS UP TO 4KG
Application Date
Application Number
144477
Application Product Name
ADVANTIX FOR PUPPIES AND SMALL DOGS UP TO 4KG
Application details
Product name:
ADVANTIX FOR PUPPIES AND SMALL DOGS UP TO 4KG
Product number:
58259
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Elanco is submitting this application to request a reduction in the storage conditions for Advantix for Puppies and Small Dogs up to 4 kg (APVMA no. 58259).
Active constituents:
Active constituent name
49016 - IMIDACLOPRID
Active constituent name
54244 - PERMETHRIN
Date
Application Date
Application No
Application Number
144636
Product/Active constituent Name
Application Product Name
PROTEKU SULPHUR DIOXIDE LAMINATED PADS
Application Date
Application Number
144636
Application Product Name
PROTEKU SULPHUR DIOXIDE LAMINATED PADS
Application details
Product name:
PROTEKU SULPHUR DIOXIDE LAMINATED PADS
Product number:
64119
Applicant Name:
E.E. MUIR & SONS PTY LIMITED
Application purpose and description of use:
Variation of product registration and label approval to add an additional pack size.
Active constituents:
Active constituent name
60365 - SODIUM METABISULPHITE
Date
Application Date
Application No
Application Number
144887
Product/Active constituent Name
Application Product Name
Azoxystrobin
Application Date
Application Number
144887
Application Product Name
Azoxystrobin
Application details
Product name:
Azoxystrobin
Active name:
Azoxystrobin
Applicant Name:
SHANGHAI E-TONG CHEMICAL CO LTD
Application purpose and description of use:
Approval of azoxystrobin for use in agricultural chemical products.
Description of data provided:
Data no
275793
Title
Five Batches Analysis of Azoxystrobin TGAI
Study date
2023
Auth party contact address
3rd Floor, Building C3 Lane 6000 Shenzhuan Road, Songjiang District China
Data no
275792
Title
Description Of Manufacturing Process Of Azoxystrobin And Impurity Information of Azoxystronbin Technical
Study date
2023
Auth party contact address
3rd Floor, Building C3 Lane 6000 Shenzhuan Road, Songjiang District China
Data no
275791
Title
Part 2 Azoxystrobin Chemistry and Manufacturing
Study date
2023
Auth party contact address
3rd Floor, Building C3 Lane 6000 Shenzhuan Road, Songjiang District China
Data no
275794
Title
Azoxystrobin Declaration of Composition (DoC)
Study date
2023
Auth party contact address
3rd Floor, Building C3 Lane 6000 Shenzhuan Road, Songjiang District China
Data no
275795
Title
Azoxystrobin COA, Declaration of Manufacture (DoM) and Letter of Support (LoS)
Study date
2023
Auth party contact address
3rd Floor, Building C3 Lane 6000 Shenzhuan Road, Songjiang District China
Data no
275796
Title
Azoxystrobin MSDS
Study date
2023
Auth party contact address
3rd Floor, Building C3 Lane 6000 Shenzhuan Road, Songjiang District China
Data no
275797
Title
Azoxystrobin FAO Specification
Study date
2009
Auth party contact address
-
Date
Application Date
Application No
Application Number
143997
Product/Active constituent Name
Application Product Name
moxidectin
Application Date
Application Number
143997
Application Product Name
moxidectin
Application details
Product name:
moxidectin
Product number:
94904
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Registration of a 900 / 657.1 / 228 / 0.9 LOTILANER/ PYRANTEL PAMOATE / PRAZIQUANTEL / MOXIDECTIN oral chewable tablet (solid oral dose form) for the treatment and control of tick species, treatment and prevention of fleas, prevention of heartworm, treatment and control of intestinal worms.
Description of data provided:
Data no
286171
Title
CoA 1 Moxidectin
Study date
June 2024
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
286172
Title
CoA 2 Moxidectin
Study date
June 2024
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
286173
Title
CoA 3 Moxidectin
Study date
June 2024
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
274350
Title
API Batch analyses
Study date
2024
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
283287
Title
3.2.S.4.2 Active constituents CoAs
Study date
2021
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
286174
Title
11Apr2025 Declaration for moxidectin
Study date
Apr 2025
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
286175
Title
01APR2025 s159 API Response to Questions AU
Study date
Apr 2025
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Date
Application Date
Application No
Application Number
143996
Product/Active constituent Name
Application Product Name
Pyrantel Embonate
Application Date
Application Number
143996
Application Product Name
Pyrantel Embonate
Application details
Product name:
Pyrantel Embonate
Product number:
94903
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Registration of a 900 / 657.1 / 228 / 0.9 LOTILANER/ PYRANTEL PAMOATE / PRAZIQUANTEL / MOXIDECTIN oral chewable tablet (solid oral dose form) for the treatment and control of tick species, treatment and prevention of fleas, prevention of heartworm, treatment and control of intestinal worms.
Description of data provided:
Data no
286167
Title
CoA 1 Pyrantel
Study date
July 2024
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
286168
Title
CoA 2 Pyrantel
Study date
July 2024
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
286170
Title
CoA 3 Pyrantel
Study date
July 2024
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Data no
286169
Title
01APR2025 s159 API Responses to Questions AU
Study date
Apr 2025
Auth party contact address
7 Eden Park Drive MACQUARIE PARK Australia
Date
Application Date
Application No
Application Number
143999
Product/Active constituent Name
Application Product Name
ADVOCATE ULTRA CHEW for Dogs 5.6 – 11 kg
Application Date
Application Number
143999
Application Product Name
ADVOCATE ULTRA CHEW for Dogs 5.6 – 11 kg
Application details
Product name:
ADVOCATE ULTRA CHEW for Dogs 5.6 – 11 kg
Product number:
94906
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Registration of a 225 / 164.3 / 57 / 0.225 MG LOTILANER/ PYRANTEL PAMOATE / PRAZIQUANTEL / MOXIDECTIN oral chewable tablet (solid oral dose form) for the treatment and control of tick species, treatment and prevention of fleas, prevention of heartworm, treatment and control of intestinal worms.
Reference details:
82857 - CREDELIO 450 mg CHEWABLE TABLETS FOR DOGS
82856 - CREDELIO 225 mg CHEWABLE TABLETS FOR DOGS
82853 - CREDELIO 900 mg CHEWABLE TABLETS FOR DOGS
82855 - CREDELIO 112.5 mg CHEWABLE TABLETS FOR DOGS
82854 - CREDELIO 56.25 mg CHEWABLE TABLETS FOR DOGS
88307 - Lotilaner
89319 - Credelio Plus Chewable Tablets for Very Large Dogs
89318 - Credelio Plus Chewable Tablets for Large Dogs
89317 - Credelio Plus Chewable Tablets for Medium Dogs
89316 - Credelio Plus Chewable Tablets for Small Dogs
89315 - Credelio Plus Chewable Tablets for Very Small Dogs
81958 - PRAZIQUANTEL
Active constituents:
Active constituent name
81958 - PRAZIQUANTEL
Active constituent name
88307 - Lotilaner
Date
Application Date
Application No
Application Number
144000
Product/Active constituent Name
Application Product Name
ADVOCATE ULTRA CHEW for Dogs 11.1 – 22 kg
Application Date
Application Number
144000
Application Product Name
ADVOCATE ULTRA CHEW for Dogs 11.1 – 22 kg
Application details
Product name:
ADVOCATE ULTRA CHEW for Dogs 11.1 – 22 kg
Product number:
94907
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Registration of a 450 / 328.6 / 114 / 0.45 LOTILANER/ PYRANTEL PAMOATE / PRAZIQUANTEL / MOXIDECTIN oral chewable tablet (solid oral dose form) for the treatment and control of tick species, treatment and prevention of fleas, prevention of heartworm, treatment and control of intestinal worms.
Reference details:
82857 - CREDELIO 450 mg CHEWABLE TABLETS FOR DOGS
82856 - CREDELIO 225 mg CHEWABLE TABLETS FOR DOGS
82853 - CREDELIO 900 mg CHEWABLE TABLETS FOR DOGS
82855 - CREDELIO 112.5 mg CHEWABLE TABLETS FOR DOGS
82854 - CREDELIO 56.25 mg CHEWABLE TABLETS FOR DOGS
88307 - Lotilaner
89319 - Credelio Plus Chewable Tablets for Very Large Dogs
89318 - Credelio Plus Chewable Tablets for Large Dogs
89317 - Credelio Plus Chewable Tablets for Medium Dogs
89316 - Credelio Plus Chewable Tablets for Small Dogs
89315 - Credelio Plus Chewable Tablets for Very Small Dogs
81958 - PRAZIQUANTEL
Active constituents:
Active constituent name
81958 - PRAZIQUANTEL
Active constituent name
88307 - Lotilaner
Date
Application Date
Application No
Application Number
144001
Product/Active constituent Name
Application Product Name
ADVOCATE ULTRA CHEW for Dogs 2.9 – 5.5 kg
Application Date
Application Number
144001
Application Product Name
ADVOCATE ULTRA CHEW for Dogs 2.9 – 5.5 kg
Application details
Product name:
ADVOCATE ULTRA CHEW for Dogs 2.9 – 5.5 kg
Product number:
94908
Applicant Name:
ELANCO AUSTRALASIA PTY LTD
Application purpose and description of use:
Registration of a 112.5 / 82.14 / 28.5 / 0.11 LOTILANER/ PYRANTEL PAMOATE / PRAZIQUANTEL / MOXIDECTIN oral chewable tablet (solid oral dose form) for the treatment and control of tick species, treatment and prevention of fleas, prevention of heartworm, treatment and control of intestinal worms.
Reference details:
82857 - CREDELIO 450 mg CHEWABLE TABLETS FOR DOGS
82856 - CREDELIO 225 mg CHEWABLE TABLETS FOR DOGS
82853 - CREDELIO 900 mg CHEWABLE TABLETS FOR DOGS
82855 - CREDELIO 112.5 mg CHEWABLE TABLETS FOR DOGS
82854 - CREDELIO 56.25 mg CHEWABLE TABLETS FOR DOGS
88307 - Lotilaner
89319 - Credelio Plus Chewable Tablets for Very Large Dogs
89318 - Credelio Plus Chewable Tablets for Large Dogs
89317 - Credelio Plus Chewable Tablets for Medium Dogs
89316 - Credelio Plus Chewable Tablets for Small Dogs
89315 - Credelio Plus Chewable Tablets for Very Small Dogs
81958 - PRAZIQUANTEL
Active constituents:
Active constituent name
81958 - PRAZIQUANTEL
Active constituent name
88307 - Lotilaner